RTALBRTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S.
4.570TRY-2.97%Mkt Cap: 2.14B TRYP/E: 5.16Last update: 2026-05-14

RTA Laboratuvarlari Biyolojik Urunler Ilac ve Makine Sanayi Ticaret A.S. engages in the research, development, and production of microbiology and molecular biology products in Turkey. It offers real-time PCR kits, nuclei…

loading…
Indicators:|

Key Statistics

Valuation
P/E (Trailing)5.16
P/E (Forward)
PEG
P/B0.72
P/S8.43
EV/EBITDA98.93
EV/Revenue8.52
EPS (TTM)0.83
EPS (Forward)
Cash Flow & Leverage
FCF Yield2.99%
FCF Margin25.19%
Operating CF-84.45M TRY
CapEx (TTM)96.45M TRY
Net Debt/EBITDA1.01
Net Debt22.05M TRY
Technical
SMA 503.733 (+22.4%)
SMA 2003.790 (+20.6%)
Beta
S&P 52W Chg24.23%
Avg Vol (30d)68.95M
Avg Vol (10d)168.12M
Technical Indicators
RSI (14)69.1
MACD0.1927
MACD Signal0.0579
MACD Hist.+0.1348
BB Upper4.610 TRY
BB Middle3.770 TRY
BB Lower2.930 TRY
BB Width44.54%
ATR (14)0.2576 TRY
Vol Ratio (20d)4.82x
52W Range
2.59080% of range5.080
52W High5.080 TRY
52W Low2.590 TRY
Profitability
Gross Margin26.55%
EBITDA Margin8.61%
Profit Margin32.94%
Oper. Margin-0.77%
ROE3.13%
ROA2.72%
Revenue Growth49.10%
Earnings Growth
Balance Sheet
Debt/Equity0.13
Current Ratio1.21
Quick Ratio0.81
Book Value/Sh5.930 TRY
Cash/Share0.0290 TRY
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 TRY
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split500:100
Split DateMar 19, 2025
Ownership
Shares Out.500.00M
Float350.00M
Insiders16.59%
Institutions4.06%
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Company
Market Cap2.14B TRY
Enterprise Value2.16B TRY
Revenue (TTM)253.76M TRY
Gross Profit42.11M TRY
Net Income (TTM)52.23M TRY
Revenue/Share0.4790 TRY
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees81
Last Price4.570 TRY
CountryTR
SectorHealthcare
IndustryBiotechnology
ISIN